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Key points summary 
 The functional importance of residues in loop G of the GABAA receptor has not been 
investigated. D43 and T47 in the α1 subunit are of particular significance as their structural 
modification inhibits activation by GABA. 
 While the T47C substitution had no significant effect, non-conservative substitution of either 
residue (D43C and T47R) reduced the apparent potency of GABA. 
 Propofol potentiated maximal GABA-evoked currents mediated by α1(D43C)β2γ2 and 
α1(T47R)β2γ2 receptors. Non-stationary variance analysis revealed a reduction in maximal 
GABA-evoked Popen, suggesting impaired agonist efficacy. 
 Further analysis of α1(T47R)β2γ2 receptors revealed that the efficacy of the partial agonist 
THIP relative to GABA was impaired.  
 GABA-, THIP- and propofol-evoked currents mediated by α1(T47R)β2γ2 receptors 
deactivated faster than those mediated by α1β2γ2 receptors indicating that the mutation 
impairs agonist-evoked gating. 
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 Spontaneous gating caused by the β2(L285R) mutation was also reduced in 
α1(T47R)β2(L285R)γ2 compared to α1β2(L285R)γ2 receptors confirming that α1(T47R) 
impairs gating independently of agonist activation. 
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Abstract 
The modification of Cys residues (substituted for D43 and T47) by 2-aminoethyl 
methanethiosulfonate in the GABAA α1 subunit loop G impairs activation of α1β2γ2 receptors by 
GABA and propofol (Baptista-Hon et al., 2016). While the T47C substitution had no significant effect, 
non-conservative substitution of either residue (D43C and T47R) reduced the apparent potency of 
GABA. Propofol (1 µM), which potentiates sub-maximal, but not maximal GABA-evoked currents 
mediated by α1β2γ2 receptors, also potentiated maximal currents mediated by α1(D43C)β2γ2 and 
α1(T47R)β2γ2 receptors. Furthermore, the peak open probabilities of α1(D43C)β2γ2 and 
α1(T47R)β2γ2 receptors were reduced. The kinetics of macroscopic currents mediated by 
α1(D43C)β2γ2 and α1(T47R)β2γ2 receptors were characterised by slower desensitisation and faster 
deactivation. Similar changes in macroscopic current kinetics, together with a slower activation rate, 
were observed with the loop D α1(F64C) substitution, known to impair both efficacy and agonist 
binding, and when the partial agonist THIP was used to activate WT or α1(T47R)β2γ2 receptors. 
Propofol-evoked currents mediated by α1(T47R)β2γ2 and α1(F64C)β2γ2 receptors also exhibited 
faster deactivation than their WT counterparts revealing that these substitutions impair gating 
through a mechanism independent of orthosteric binding. Spontaneous gating caused by the 
introduction of the β2(L285R) mutation was also reduced in α1(T47R)β2(L285R)γ2 compared to 
α1β2(L285R)γ2 receptors confirming that α1(T47R) impairs gating independently of activation by any 
agonist. These findings implicate movement of the GABAA receptor α1 subunit’s β1 strand during 
agonist dependent and spontaneous gating. Immobilisation of the β1 strand may provide a 
mechanism for the inhibition of gating by inverse agonists such as bicuculline. 
Abbreviations list 
DMEM, Dulbecco modified Eagle’s medium; GABA, γ-aminobutyric acid; GluCl, glutamate-activated 
Cl- channel; HEK-293, human embryonic kidney 293 cell; MD, molecular dynamic; MTSEA, 2-
aminoethyl methanethiosulfonate; pLGIC, pentameric ligand-gated ion channel; THIP, 4,5,6,7-
tetrahydroisoxazolo[5,4-c]pyridine-3-ol; TM, transmembrane; τw, weighted tau.   
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Introduction 
γ-Aminobutyric acid type A (GABAA) receptors are Cys-loop receptors of the pentameric ligand-gated 
ion channel (pLGIC) family. They mediate fast inhibitory neurotransmission. Nineteen different genes 
encode GABAA receptor subunits, providing considerable heterogeneity in GABAA receptor 
composition. The most abundant GABAA receptors in the brain are comprised of α1, β2 and γ2 
subunits (Whiting et al., 1995).  
In common with other pLGICs, GABAA receptors have an N-terminal extracellular domain, which 
contains the orthosteric agonist binding site and four transmembrane (TM) domains (TM1-4) 
containing additional binding sites for positive modulators and allosteric agonists, such as the 
general anaesthetic propofol. The Cl--selective channel pore, containing the gate, is encompassed by 
five TM2 domains arranged pseudo-symmetrically (Miller & Aricescu, 2014). The intracellular 
domains of pLGICs are generally large, being mostly composed of the TM3-4 loop (Baptista-Hon et 
al., 2013). TM domains are most highly conserved across pLGICs, while the intracellular loops are 
highly heterogeneous.  
The orthosteric binding site of the GABAA receptor is located in the N-terminal domain between 
adjacent α- and β- subunits (Smith & Olsen, 1995; Cromer et al., 2002). In this region, seven non-
contiguous loops (A-G) line the orthosteric site, where they participate in agonist binding (Boileau et 
al., 1999; Holden & Czajkowski, 2002; Wagner et al., 2004; Goldschen-Ohm et al., 2011; Tran et al., 
2011) and/or gating (Boileau et al., 2002; Newell & Czajkowski, 2003; Venkatachalan & Czajkowski, 
2008; Szczot et al., 2014; Baptista-Hon et al., 2016). These loops are contained within an anti-parallel 
β sandwich structure. In the canonical α1β2γ2 GABAA receptor, loops A, B and C are contributed by 
the primary interface, from the β2 subunit, while loops D, E, F and loop G are contributed by the 
complimentary interface, from the α1 subunit.  
Arg37 in loop G was recently identified for its role in glutamate binding to the Caenorhabditis 
elegans glutamate-activated Cl- (GluCl) pLGIC (Hibbs & Gouaux, 2011). However, residues in this 
region are not implicated in binding agonists to other pLGICs, such as the GABAA β3 homopentamer 
(Miller & Aricescu, 2014), the glycine receptor (Du et al., 2015) or the α4β2 nicotinic acetylcholine 
receptor (Morales-Perez et al., 2016). Despite a lack of involvement in binding to GABAA receptors, 
there is considerable homology among loop G amino acids between α subunits, consistent with a 
conserved role in receptor function (Fig. 1A). 
  
 
This article is protected by copyright. All rights reserved. 
5 
 
The potential importance of loop G during gating is highlighted by comparisons of apo- and agonist 
bound structures of the glycine receptor (Du et al., 2015) and GluCl (Althoff et al., 2014). The β1 
strand containing loop G, the β2 strand containing loop D and the interconnecting β1-β2 loop, move 
towards the TM2-3 loop in the presence of bound agonist. This movement appears to precede the 
structural rearrangement of the TM domains that leads to channel opening (Calimet et al., 2013).  
We recently demonstrated the involvement of specific GABAA receptor α1 subunit loop G residues in 
function using cysteine-scanning mutagenesis (Baptista-Hon et al., 2016). D43C was the only one of 
five loop G substituents to reduce the apparent potency of GABA. Furthermore, its modification by 
positively charged 2-aminoethyl methanethiosulfonate (MTSEA) caused additional functional 
impairment. By contrast, while T47C did not significantly affect GABA’s potency, its modification by 
MTSEA inhibited GABA-evoked currents. Cysteines substituted at three other positions in loop G of 
the α1 subunit (residues 44, 45 and 46) were either inaccessible to MTSEA or their modification was 
without functional consequence (Baptista-Hon et al., 2016).     
In this study we investigated whether amino acid substitutions at positions 43 and 47 that impair 
function do so by impairing gating. In order to replicate MTSEA modified α1(T47C), which impairs 
function (Baptista-Hon et al., 2016), we replaced Thr47 by Arg. We compared the efficacy of GABA as 
an activator of α1(D43C)β2γ2, α1(T47R)β2γ2 and α1β2γ2 receptors using analysis of channel open 
probability (Popen) and potentiation by the positive allosteric modulator propofol. We investigated 
the kinetics of THIP- and propofol-evoked currents mediated by α1(T47R)β2γ2 receptors. We also 
examined the influence of α1(T47R) substitution on receptors containing the β2(L285R) substitution, 
which causes enhanced spontaneous gating. Using these approaches, we established that non-
conservative substitutions at two key positions in loop G reduce gating efficacy. 
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Methods 
Cell culture and transfection - Human embryonic kidney 293 (HEK-293) cells were grown and 
maintained in Dulbecco Modified Eagle’s Medium (DMEM) supplemented with 10% fetal bovine 
serum, 100 µg ml-1 penicillin and 100 units ml-1 streptomycin at 37oC and 5% CO2. Cells were seeded 
at low density in either poly-L-lysine coated, or uncoated 35 mm dishes for outside-out patch 
recordings or whole-cell recordings, respectively. Transfections were performed by calcium 
phosphate precipitation, using 1 µg total cDNA per dish, as described previously (Baptista-Hon et al., 
2016). cDNAs encoding wild type (WT) and mutant mouse GABAA subunits were in the pRK5 
mammalian expression vector. For heteromeric expression of GABAA α1β2γ2 subunits, a 1:1:1 
transfection ratio was used. cDNA encoding enhanced green fluorescence protein (in pEGFP vector, 
0.1 µg) was included to identify successfully transfected cells using fluorescence microscopy. 
Transfected cells were functionally examined using voltage-clamp electrophysiology after 48 to 72 h. 
All tissue culture reagents were obtained from Invitrogen (Paisley, UK). 
Mutagenesis of GABAA α1 and β2 subunits – Single point mutations were performed by overlap 
extension polymerase chain reaction (PCR) (Heckman & Pease, 2007). For α1 subunits, PCR products 
were digested using SmaI restriction endonuclease and EcoRI (5’) and BamHI (3’) restriction 
endonucleases were used for β2 subunits. All GABAA receptor subunits were ligated into pRK5 
vector. All mutagenesis reactions and ligations were verified using agarose gel electrophoresis and 
sequenced prior to functional characterisation (Genetics Core Services, University of Dundee). All 
PCR and molecular cloning reagents were obtained from Fermentas (Thermo-Fisher, Loughborough, 
UK). 
Electrophysiology - The whole-cell or excised outside-out patch configurations of the patch-clamp 
technique was used to record GABA-evoked currents from HEK-293 cells expressing WT, or mutant, 
GABAA receptors. Recording electrodes were fabricated from borosilicate glass capillaries, and when 
filled with intracellular solution had resistances of 1.3 – 2.3 MΩ for whole-cell recordings, and 3.0 – 
5.0 MΩ for outside-out patch recordings. The electrode solution contained (in mM): 140 CsCl, 2 
MgCl2, 1.1 EGTA, 3 Mg-ATP and 10 HEPES (pH 7.4 with CsOH). The extracellular solution contained 
(in mM): 140 NaCl, 4.7 KCl, 1.2 MgCl2, 2.5 CaCl2, 10 HEPES and 10 glucose (pH 7.4 with NaOH). Cells 
were voltage clamped at an electrode potential of -60 mV. For whole-cell recordings, currents were 
evoked by rapid application of agonists using the three-pipe Perfusion Fast Step system (Warner 
Instruments, CA, USA), as described previously (Baptista-Hon et al., 2016).  
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For outside-out patch recordings, maximally efficacious and saturating concentrations of agonists 
were applied also using the Perfusion Fast Step system, with heat pulled and bevelled (Narashige, 
London, UK) theta and three-barrelled pipes (Othman et al., 2012). This allows rapid solution 
exchange consistently of <500 s around an open pipette tip (Hinkle & Macdonald, 2003). Solution 
exchange times were measured using liquid junction currents arising from moving the open pipette 
tip into an extracellular solution diluted by 10%. The 10-90% rise time of the liquid junction current 
was used as a measure of solution exchange rate. Liquid junction currents were routinely measured 
at the end of every outside-out patch recording, to ensure the fidelity of fast solution exchange. For 
experiments examining the macroscopic current kinetics of propofol-evoked currents, the 
concentration of propofol used was chosen on the basis that the evoked current does not contain a 
surge following propofol removal, which is mediated by propofol blockade (Hadley & Amin, 2007). 
All electrophysiological data were recorded using an Axopatch 200B amplifier. Data were low pass 
filtered at 2 kHz for whole cell currents and 10 kHz for outside-out patch currents. Analog data were 
digitised at 20 kHz for whole cell currents and 100 kHz for outside-out patch currents using a 
Digidata 1320A interface and acquired using pCLAMP8 software (all from Molecular Devices, CA, 
USA). 
Data analysis - The peak amplitudes of agonist-evoked currents were measured using Clampfit10 
software (Molecular Devices, CA, USA), using averaged current traces from at least five agonist-
evoked currents. The potentiating effects of propofol on peak GABA-evoked currents were analysed 
as percentage potentiation, using the formula: 
                
(          )
     
     
Where Ipot and IGABA represent the potentiated and control peak current amplitudes, respectively. 
Non-stationary variance analysis was performed as described by Szczot et al (2014). A minimum of 
10 consecutive responses to a 5 ms application of maximally efficacious and saturating 
concentration of GABA were recorded from outside-out patches, using the rapid application method 
described above. The currents were analysed using a custom-written script in MatLab (The 
Mathworks, Inc., Natick, Massachusetts, U.S.A.). The rising phase of each current was excluded from 
the analysis. The starting point for analysis was therefore set at the peak of the current. Mean 
current (I) and variance (σ2) at each time point were divided into 30 equally spaced bins and plotted 
as I vs σ2, which were fitted with the following function: 
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Where i is the single channel amplitude, N is the number of channels and C is the background 
variance. From these parameters, the maximal open probability (Popen) was calculated by: 
              
      
   
 
Single channel conductance was calculated by dividing the single channel amplitude (i) by the 
membrane holding potential (-60 mV). 
Activation rates were measured using the 10 - 90% rise time of agonist-evoked inward current. 
Macroscopic desensitisation and deactivation kinetics were measured by fitting multi-exponential 
functions to the decaying phase of the inward current, during or following agonist application, 
respectively. The multi exponential function is defined by: 
 ( )     
  
  ⁄      
  
  ⁄  
Where τN represent time constants and AN represent the proportion of the particular τ. The best-fit 
number of exponential terms (1 to 3 terms) were determined using an F-test with the confidence set 
at the 95% level. Rates of desensitisation and deactivation are provided as weighted τ (τw) values, 
calculated using: 
                
Individual GABA concentration vs current amplitude relationships were fitted with a logistics 
equation: 
 (      )  
   
    (              )  
 )
 
From which GABA EC50 and Hill slope (n
H) values were determined. 
Statistics - Data are presented as mean ± S.E.M. Differences in means of three or more groups were 
compared using one-way analysis of variance (ANOVA), with a post-hoc Dunnet’s or Tukey’s 
comparison. Pairwise comparisons were performed using the student t-test. In all cases P < 0.05 was 
considered statistically significant. Statistical analyses were performed using GraphPad Prism 5 
(GraphPad Software, San Diego, California, U.S.A.). 
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Results 
Residues in loop G and loop D influence the apparent potency of GABA  
Loop G of the GABAA receptor α subunit contributes residues to the complimentary interface near 
the orthosteric binding site in heteropentameric GABAA receptors. The alignment reveals that the α1 
subunit Thr47 is entirely conserved among all GABAA α subunits at the position equivalent to that of 
Arg37 in the C. elegans GluCl α subunit (Fig. 1A). Asp43, an α1 subunit residue we previously 
demonstrated to be important for GABAA receptor function (Baptista-Hon et al., 2016) is also 
conserved in all but the α2 subunit, which contains an Asn at the equivalent position. Loop G runs 
adjacent and anti-parallel to loop D on the β2 strand. The location of a critical loop D residue, Phe64, 
known to participate in GABA binding and efficacy is also shown in the alignment (Boileau et al., 
1999; Szczot et al., 2014). Residues in these positions are highlighted on the GluCl structure in 
relation to bound glutamate (Fig. 1B) (Hibbs & Gouaux, 2011). GluCl Arg37 in loop G forms part of 
the glutamate binding site and is involved in receptor activation (Hibbs & Gouaux, 2011). We 
investigated the influence of  the T47R substitution on GABAA α1β2γ2 receptor function. Our 
previous study demonstrated that a non-conservative substitution to Asp43 (D43C) in loop G of the 
GABAA α1 subunit significantly reduced the apparent potency of GABA (Baptista-Hon et al., 2016). 
WT α1 or α1(T47R) subunits were transiently expressed with β2 and γ2 subunits in HEK-293 cells. 
Representative examples of GABA-evoked currents recorded under voltage-clamp at -60 mV from 
cells expressing α1β2γ2 or α1(T47R)β2γ2 receptors are shown in Figure 1C. GABA-evoked current 
amplitudes were expressed as a percentage of the maximum and plotted as a concentration-
response relationship (Fig. 1D). A logistic function fitted to the data points reveals that the α1(T47R) 
substitution caused a rightward shift in the GABA concentration-response relationship (Fig 1D). The 
EC50 for GABA activation of WT α1β2γ2 receptors was 17 ± 5 µM (n = 7). The EC50 for GABA activation 
of α1(T47R)β2γ2 receptors was 1500 ± 320 µM (n = 7). The non-conservative D43C substitution in 
loop G of the GABAA α1 subunit produced a similar reduction in the apparent potency of GABA 
(Baptista-Hon et al., 2016).  
Phe64, which is located on the adjacent and anti-parallel loop D is involved in GABA binding and 
gating (Boileau et al., 1999; Szczot et al., 2014). The α1(F64C) substitution causes a significant 
reduction in the apparent potency of GABA (Boileau et al., 1999; Szczot et al., 2014; Baptista-Hon et 
al., 2016). Substitution of Phe64 with the equivalent residue found at this position in GluCl (F64T) 
caused a similar impairment in the apparent potency of GABA. The EC50 of α1(F64T)β2γ2 receptors 
was 16 ± 1 mM (n = 3). A one-way ANOVA revealed a significant difference between the GABA EC50 
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values (P < 0.0001). A post-hoc Tukey’s comparison revealed statistically significant differences in 
GABA EC50 between WT and α1(T47R)β2γ2 receptors (P < 0.05), between WT and α1(F64T)β2γ2 
receptors (P < 0.0001) and also between α1(T47R)β2γ2 and α1(F64T)β2γ2 receptors (P < 0.0001). 
There were no statistically significant differences in the Hill slope values of the GABA concentration-
response relationships (P = 0.24; one-way ANOVA). This observation suggests that the number of 
GABA binding sites remains the same and argues against altered stoichiometry caused by the α1 
subunit substitutions. We also evaluated the peak current density of α1β2γ2, α1(T47R)β2γ2 and 
α1(F64T)β2γ2 receptors, by normalising the current amplitude evoked by maximally efficacious 
concentrations of GABA, to cell capacitances.  The mean (± S.E.M.) current densities are 1510 ± 264 
pA pF-1 (n = 18), 684 ± 119 pA pF-1 (n = 24) and 401 ± 155 pA pF-1 (n = 5), for α1β2γ2, α1(T47R)β2γ2 
and α1(F64T)β2γ2 receptors, respectively. There was a statistically significant difference in peak 
current density (P = 0.003; one-way ANOVA). A post-hoc Tukey’s comparison revealed significant 
reductions in the mean current densities for α1(T47R)β2γ2 (P < 0.001), and α1(F64T)β2γ2 receptors 
(P < 0.05), when compared with α1β2γ2 receptors. We have previously reported a reduction in 
current density for α1(D43C)β2γ2 and α1(F64C)β2γ2 receptors, compared to WT receptors (Baptista-
Hon et al., 2016). 
The identities of residues in Loop G at positions 43 and 47 influence agonist efficacy 
Apparent potencies, determined from concentration-response relationships, are composites of 
agonist binding affinity and gating efficacy (Colquhoun, 1998). Therefore, reductions in EC50 values 
for α1(D43C)β2γ2 and α1(T47R)β2γ2 receptors compared to WT could be caused by reduced GABA 
affinity and/or efficacy. We investigated the possibility that D43C and T47R substitutions might 
impair the efficacy of GABA using propofol, a general anaesthetic that acts as a positive allosteric 
modulator of GABAA receptors (Berger et al., 1997). Co-application of propofol (1 µM) with an EC50 
concentration of GABA (10 µM) to HEK-293 cells expressing α1β2γ2 receptors caused current 
amplitudes to increase by 62 ± 18% (n = 4), relative to currents evoked by GABA (10 µM) alone. The 
application of propofol (1 µM) alone had no effect (data not shown). We subsequently tested the 
ability of propofol (1 µM) to potentiate currents evoked by maximally efficacious concentrations of 
GABA mediated by α1β2γ2 (1 mM), α1(D43C)β2γ2 (100 mM), α1(T47R)β2γ2 (30 mM) and 
α1(F64C)β2γ2 receptors (300 mM). GABA concentrations were chosen based on the concentration-
response relationship shown in Figure 1D for α1β2γ2 and α1(T47R)β2γ2 receptors, and our 
previously published concentration-response relationships for α1(D43C)β2γ2 and α1(F64C)β2γ2 
receptors (Baptista-Hon et al., 2016). Figure 2A shows representative examples of maximal GABA-
evoked currents in the presence or absence of propofol. Co-application of propofol with GABA to 
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cells expressing α1β2γ2 receptors did not cause any potentiation, consistent with GABA having full 
efficacy. By contrast, recordings from cells expressing α1(D43C)β2γ2 or α1(T47R)β2γ2 receptors 
revealed that the co-application of GABA with propofol increased current amplitudes relative to 
GABA alone (Fig. 2A). This suggests that GABA lacks full efficacy at α1(D43C)β2γ2 and α1(T47R)β2γ2 
receptors. The loop D α1(F64C) substitution is known to reduce the efficacy of GABA (Szczot et al., 
2014). Consistent with this observation, we found that co-application of GABA (300 mM) with 
propofol (1 µM) also increased the current amplitude relative to GABA (300 mM) alone at 
α1(F64C)β2γ2 receptors (Fig. 2A). We quantified the effect of propofol on maximal GABA-evoked 
currents (Fig. 2B). The graph shows data expressed as mean percent potentiation by propofol. 
Currents mediated by α1β2γ2 receptors were unaffected by propofol (-0.72 ± 1.6%; n = 5). By 
contrast, propofol (1 µM) potentiated maximal GABA-evoked currents mediated by α1(D43C)β2γ2, 
α1(T47R)β2γ2 and α1(F64C)β2γ2 receptors by 19 ± 5% (n = 9), 23 ± 5% (n = 9) and 47 ± 8% (n = 4), 
respectively (Fig. 2B). The differences in mean percentage potentiation were statistically significant 
(P < 0.0001; one-way ANOVA). A post-hoc Tukey’s comparison revealed a statistically significant 
difference in propofol potentiation of maximal GABA-evoked currents between α1β2γ2 and 
α1(D43C)β2γ2 (P < 0.05), α1(T47R)β2γ2 (P < 0.001) and α1(F64C)β2γ2 receptors (P < 0.0001). There 
is also a significant difference in propofol potentiation between α1(F64C)β2γ2 and either 
α1(D43C)β2γ2 (P < 0.001) or α1(T47R)β2γ2 receptors (P < 0.05). These data indicate that D43C and 
T47R substitutions impair the efficacy of GABA, albeit to a lesser extent than the F64C substitution. 
We examined whether the reduced efficacy of GABA as an agonist at α1(D43C)β2γ2 or 
α1(T47R)β2γ2 was associated with reduced maximal open probabilities (Popen) of GABA-activated 
channels as would be expected for mutations that affect gating. We calculated Popen using non-
stationary variance analysis of maximal GABA-evoked currents. This approach has been used 
previously to demonstrate that the Popen of GABAA receptors containing the α1(F64C) substitution 
was reduced (Szczot et al., 2014). Currents evoked by brief (5 ms) rapid applications of maximally 
efficacious concentrations of GABA were recorded from outside-out patches containing α1β2γ2, 
α1(D43C)β2γ2 or α1(T47R)β2γ2 receptors. A minimum of 10 consecutive GABA-evoked currents 
were used to calculate mean current (I) and variance (σ2) for each time point. Representative 
examples of variance and mean current are shown for α1β2γ2 and α1(T47R)β2γ2 receptors (Fig. 3A). 
The rising phases of the currents were not included in the analysis (grey portion in Fig. 3A). A 
parabolic function was fitted to the plot of mean current versus variance to determine the single 
channel amplitude and the number of channels (Fig. 3B). From these values, the single channel 
conductance (γ) and maximal Popen were calculated (See Methods). Neither the α1(D43C) nor 
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α1(T47R) substitutions significantly altered γ (Fig. 3C; P = 0.96; one-way ANOVA). The mean 
maximum Popen values for α1β2γ2, α1(D43C)β2γ2 and α1(T47R)β2γ2 receptors were 0.78 ± 0.05 (n = 
8), 0.50 ± 0.09 (n = 5) and 0.56 ± 0.05 (n = 7), respectively (Fig. 3D). One-way ANOVA revealed a 
statistically significant difference in mean maximal Popen (P = 0.0083). A post-hoc Tukey’s comparison 
determined a statistically significant difference in mean maximal Popen between α1β2γ2 and 
α1(D43C)β2γ2 receptors (P < 0.05), and between α1β2γ2 and α1(T47R)β2γ2 receptors (P < 0.05). 
These data agree well with the results of propofol potentiation experiments and indicate that the 
α1(D43C) and α1(T47R) substitutions reduce the efficacy of GABA by reducing the maximal Popen of 
GABAA receptors to a similar extent.  
Substitutions in loop G and loop D have common effects on GABA-evoked gating kinetics                 
We used rapid GABA application to outside-out patches excised from HEK-293 cells to investigate 
the kinetics of macroscopic currents mediated by recombinant α1(D43C)β2γ2, α1(T47R)β2γ2 and 
α1(F64C)β2γ2 receptors. Figure 4A shows representative examples of currents evoked by maximal 
concentrations of GABA, recorded at -60 mV from patches containing α1β2γ2, α1(D43C)β2γ2, 
α1(T47R)β2γ2 and α1(F64C)β2γ2 receptors. Macroscopic currents mediated by α1(F64T)β2γ2 
receptors resemble those of α1(F64C)β2γ2 receptors and are not shown. Traces in Figure 4B are 
amplitude-normalised rising phases mediated by α1β2γ2, α1(T47R)β2γ2 and α1(F64C)β2γ2 
receptors. Current activation rates were quantified as 10 - 90% rise-times. Mean activation times are 
plotted in the bar graph (Fig. 4B). Comparison of the mean rise-times reveals a statistically significant 
difference between these receptor subtypes (P < 0.0001; one-way ANOVA; Fig. 4B; Table 1). Currents 
mediated by both α1(F64C)β2γ2 and α1(F64T)β2γ2 receptors were activated more slowly than 
α1β2γ2 (P < 0.0001) and also when compared with α1(D43C)β2γ2 (P < 0.0001) and α1(T47R)β2γ2 
receptors (P < 0.0001, post-hoc Tukey’s comparison). The activation rates between α1β2γ2, 
α1(D43C)β2γ2 and α1(T47R)β2γ2 receptors did not differ significantly. However, there was a trend 
towards a slower activation rate for both loop G substitutions.  
GABA-evoked currents decay in the continued presence of the agonist through the process of 
desensitisation. We quantified desensitisation by measuring current remaining at the end of the 
GABA application and expressing it as a percentage of peak current amplitude. The averaged values 
are plotted in Figure 4C. Comparison of these values reveals a significant difference between the 
receptor subtypes (P = 0.0003; one-way ANOVA; Fig. 4C). GABA-evoked currents mediated by 
α1(D43C)β2γ2, α1(F64C)β2γ2 and α1(F64T)β2γ2 receptors desensitised significantly less than those 
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mediated by α1β2γ2 receptors (P < 0.001, post-hoc Tukey’s comparison). The extent of 
desensitisation did not significantly differ between α1β2γ2 and α1(T47R)β2γ2 receptors.  
It was possible to fit exponential functions to evaluate the apparent desensitisation rates for 
α1β2γ2, α1(D43C)β2γ2 and α1(T47R)β2γ2 receptors. An F-test (see Methods) revealed that a three-
component exponential function consistently yielded the best fit to the desensitising current. The 
components of the multi-exponential function were used to calculate w (see Methods) and the 
mean values of w are plotted in Figure 4D. There was no significant difference in mean w
 values (P = 
0.08; one-way ANOVA), although visual inspection of the exemplar traces in Figure 4A shows 
apparent differences in the time course of desensitisation between α1β2γ2, α1(D43C)β2γ2 and 
α1(T47R)β2γ2 receptors. Indeed, analysis of the individual components of desensitisation reveals 
significant differences (Table 1). The α1(D43C) and α1(T47R) substitutions influence the fastest 
component of apparent desensitisation by reducing the rate and the percentage, respectively. There 
was also an increase in the contribution of the slowest time constant to apparent desensitisation for 
α1(D43C)β2γ2 and α1(T47R)β2γ2 receptors. The intermediate component was not affected by the 
substitutions. These analyses indicate that the loop G α1(D43C) and α1(T47R) substitutions cause 
similar changes in desensitisation kinetics. 
Traces in Figure 4E show amplitude normalised deactivation time courses of α1β2γ2, α1(T47R)β2γ2 
and α1(F64C)β2γ2 receptors. The deactivation traces for α1(D43C)β2γ2, α1(T47R)β2γ2 
α1(F64C)β2γ2 and α1(F64T)β2γ2 receptors are indistinguishable from each other. Therefore, for 
clarity, examples of α1(D43C)β2γ2 and α1(F64T)β2γ2 receptors are not shown. An F-test revealed 
that a three-component exponential function best describes the deactivation time course in α1β2γ2, 
α1(D43C)β2γ2 and α1(T47R)β2γ2 receptors. For α1(F64C)β2γ2 and α1(F64T)β2γ2 receptors, the 
slowest component was lost and the deactivation time courses were best described with a two-
exponential function. Comparison of the mean w values for deactivation of GABA-evoked currents 
mediated by the different receptor subtypes revealed a statistically significant difference (P < 
0.0001; one-way ANOVA; Fig. 4E; Table 2). There were significant differences between the w values 
for α1β2γ2 and α1(D43C)β2γ2, α1(T47R)β2γ2, α1(F64C)β2γ2 and α1(F64T)β2γ2 receptors (all P < 
0.0001, post-hoc Tukey’s comparison). The individual components of the multi-exponential fits are 
summarised in Table 2. Macroscopic currents mediated by GABAA receptors containing the loop D 
α1(F64C) and α1(F64T) substitutions were more severely affected, in terms of activation rates and 
extent of apparent desensitisation, than were those containing the α1(D43C) and α1(T47R) 
substitutions. By contrast, deactivation rates were similarly affected by all substitutions in loops G 
and D. 
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Kinetics of currents activated by the partial agonist THIP  
In the preceding investigation of GABA efficacy and gating kinetics, the loop G α1(D43C) and 
α1(T47R) substitutions had similar effects. We therefore restricted our subsequent analysis to the 
α1(T47R) substitution using the loop D α1(F64C) substitution as a comparator.  
Propofol potentiation and maximal Popen data suggest that the efficacy of GABA is impaired by non-
conservative substitutions in loop G. These changes in efficacy were associated with dramatically 
increased deactivation rates and changes in desensitisation kinetics. We investigated currents 
evoked by THIP, a partial agonist at WT GABAA α1β2γ2 receptors to determine whether these are 
kinetic hallmarks of partial agonism. 
We verified that THIP is a partial agonist when applied rapidly (see Methods) to excised outside-out 
patches containing α1β2γ2 receptors. Maximally effective concentrations of GABA and THIP were 
chosen on the basis of concentration-response relationships (Fig. 1D) and the observation that 
higher agonist concentrations did not further increase current amplitude when applied rapidly to 
outside-out patches (data not shown). Figure 5A shows representative examples of maximally 
effective GABA- and THIP-evoked currents recorded from outside-out patches containing α1β2γ2 
and α1(T47R)β2γ2 receptors. THIP-evoked currents mediated by α1β2γ2 receptors were smaller 
than those activated by GABA (Fig. 5B). The exemplar data reveal a further reduction in the relative 
THIP-evoked current amplitude mediated by α1(T47R)β2γ2 receptors, consistent with our data 
above that this non-conservative substitution reduces agonist efficacy. THIP did not evoke 
measurable currents at α1(F64C)β2γ2 receptors (data not shown). The relative efficacy of THIP at 
α1β2γ2 receptors, was on average 77 ± 5% of that of GABA (n = 5; Fig. 5B). The relative efficacy of 
THIP as an agonist of α1(T47R)β2γ2 receptors was reduced to 17 ± 3% of that of GABA (n = 6). The 
reduction in THIP efficacy at α1(T47R)β2γ2 receptors was statistically significant (P = 0.0001; t-test; 
Fig. 5B). 
Inspection of α1β2γ2 receptor-mediated currents reveals that those activated by THIP and GABA 
exhibit differing kinetics (Fig. 5A). The normalised current traces in Figure 5C illustrate the rising 
phases of GABA- and THIP-evoked currents mediated by WT receptors. We compared their 
activation rates by measuring the time for currents to increase from 10% to 90% of their peaks (Fig. 
5C). THIP-evoked currents activated significantly more slowly than did GABA-evoked currents (P < 
0.0001; t-test). 
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The apparent desensitisation time course for THIP-evoked currents mediated by α1β2γ2 receptors 
was best described using a three-component exponential function. THIP-evoked currents showed 
subtle differences in desensitisation kinetics compared with GABA-evoked currents. There was no 
statistically significant difference in the τw between GABA-evoked and THIP-evoked currents (Fig. 5D; 
P = 0.29; t-test). The individual time constants and their relative proportions are summarised in 
Table 1. There was a significant reduction in the proportion of the fastest desensitisation 
component, and a concurrent significant increase in the slowest component. The effect of a partial 
agonist on desensitisation time course at α1β2γ2 receptors is similar to those caused by the loop G 
α1(D43C) and α1(T47R) substitutions, which impaired efficacy. 
Traces in Figure 5E (normalised to the amplitude at the end of a 500 ms GABA application) are 
examples of GABA- and THIP-evoked current deactivation mediated by WT receptors. The 
deactivation time course for THIP-evoked currents were best described using a triple exponential 
function, similar to GABA-evoked currents. Comparison of mean τw values reveal that THIP-evoked 
currents deactivate significantly faster than GABA-evoked currents (P = 0.0008, t-test; Fig. 5E). The 
individual components of the deactivation kinetics are summarised in Table 2. The increase in the τw 
of deactivation can be attributed to a significant reduction in all three time constants and a shift in 
the proportion from the slowest to the fastest component. These data agree well with our findings 
above that partial agonism is associated with an increase in deactivation rate, but also, to a lesser 
extent, with slower activation and desensitisation kinetics. These findings support a previous report 
of kinetics associated with partial efficacy using single channel recording (Mortensen et al., 2004) 
and imply that slow activation, slow desensitisation and fast deactivation are associated with weaker 
agonists.  
In the presence of the α1(T47R) substitution, the efficacy of THIP is further reduced relative to GABA 
(Fig. 5A). We therefore compared the macroscopic kinetics of THIP-evoked currents mediated by 
α1β2γ2 and α1(T47R)β2γ2 receptors. The current traces in Figure 5F show amplitude normalised 
rising phases of THIP-evoked currents mediated by α1β2γ2 and α1(T47R)β2γ2 receptors. The bar 
graph shows mean 10 - 90% rise times. THIP-evoked currents mediated by α1(T47R)β2γ2 receptors 
were activated significantly more slowly than those mediated by α1β2γ2 receptors (P = 0.002; t-test; 
Fig. 5F; Table 1).  
Currents mediated by α1(T47R)β2γ2 receptors desensitised too slowly to allow fitting with an 
exponential function (see Fig. 5A). Therefore, we examined desensitisation by measuring the current 
remaining at the end of the THIP application as a percentage of that at its peak. This approach 
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revealed a significant reduction in the extent of THIP-evoked current desensitisation mediated by 
α1(T47R)β2γ2 receptors compared to those mediated by α1β2γ2 receptors (P = 0.0001; t-test; Fig. 
5G; Table 1).  
The current traces in Figure 5H show amplitude normalised deactivation phases from THIP-evoked 
currents at α1β2γ2 and α1(T47R)β2γ2 receptors. The deactivation of THIP-evoked currents mediated 
by α1(T47R)β2γ2 receptors was consistently best described using two exponential terms, compared 
to three terms necessary to adequately describe deactivation mediated by α1β2γ2 receptors. 
Analysis of the mean w values reveals a significant reduction of the w values for the activation of 
THIP-evoked currents mediated by α1(T47R)β2γ2 receptors compared to WT receptors (P = 0.0001; 
t-test; Fig. 3G; Table 2). There was a significant reduction in the fastest time constant, as well as a 
significant increase in its proportion. As mentioned above, the slowest deactivation time constant 
present in recordings of THIP-evoked currents mediated by WT receptors were not seen in recording 
of currents mediated by α1(T47R)β2γ2 receptors. These data agree well with the other macroscopic 
current kinetic data showing progressively increasing effects on activation and deactivation rates 
with reductions in agonist efficacy.  
Deactivation kinetics of propofol-evoked currents 
It is possible that the changes in current kinetics quantified above (slow activation, slow 
desensitisation and fast deactivation), caused by mutations in the vicinity of the orthosteric binding 
site are composites of altered rates of agonist association and dissociation, agonist efficacy and 
desensitisation. This might be expected particularly for the α1(F64C) mutation, which affects agonist 
binding. In order to examine the effect of amino acid substitutions in loop G and loop D on receptor 
gating, independent of orthosteric agonist binding we examined the kinetics of currents activated by 
the allosteric agonist propofol mediated by α1β2γ2, α1(T47R)β2γ2 and α1(F64C)β2γ2 receptors. The 
concentration of propofol used, which evoked robust currents without evidence of block, was either 
30 or 100 µM, and did not differ between the receptor subtypes, suggesting that the potency for 
propofol was not dramatically affected by the amino acid substitutions. The activation time course 
of propofol (30 or 100 µM)-evoked currents mediated by α1β2γ2 receptors, was independent of 
concentration (data not shown). 
Figure 6A shows representative examples of propofol-evoked currents recorded from outside-out 
patches containing α1β2γ2, α1(T47R)β2γ2 and α1(F64C)β2γ2 receptors. The current traces in Figure 
6B are amplitude normalised rising phases of propofol-evoked currents mediated by WT and mutant 
receptors. We measured activation rate as the 10 - 90% rise time. The means are plotted in the bar 
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graph (Fig. 6B). The α1(T47R) and α1(F64C) substitutions did not significantly affect the 10 - 90% rise 
time of propofol-evoked currents (P = 0.51; one-way ANOVA). 
Propofol (30 or 100 µM)-evoked currents did not exhibit measurable apparent desensitisation and 
therefore this parameter was not analysed (Fig. 6A). Traces in Figure 6C are amplitude normalised 
deactivation phases of propofol-evoked currents mediated by α1β2γ2, α1(T47R)β2γ2 and 
α1(F64C)β2γ2 receptors. A double exponential best describes the deactivation time course and the 
mean w is plotted in the bar graph (Fig. 6C). Comparison of the w values for deactivation revealed a 
significant differences (one-way ANOVA) between α1β2γ2, α1(T47R)β2γ2 (P < 0.0001) and 
α1(F64C)β2γ2 (P < 0.0001, post-hoc Tukey’s comparison). The w of deactivation did not differ 
between different mutant receptors. These data demonstrate that the deactivation rate for the 
allosteric agonist propofol is affected by the T47R and F64C substitutions, suggesting that loop D 
Phe64 and loop G Thr47 are involved in gating of α1β2γ2 GABAA receptors independent of 
occupation of the orthosteric binding site. 
α1 subunit T47R reduces spontaneous gating 
Our observation that propofol-evoked currents were influenced by the α1(T47R) substitution 
suggests that loop G Thr47 influences gating regardless of the occupancy of the orthosteric binding 
site. In order to examine the influence of the α1(T47R) and α1(F64C) substitutions on GABAA 
receptor gating independent of any agonist activation, we studied their effects on GABAA receptors 
that display enhanced spontaneous gating. Leu285 is a conserved residue in all β-subunits located in 
TM3. The GABAA β1(L285R) substitution is associated with alcohol preference and enhanced 
spontaneous gating (Anstee et al., 2013).  
We first determined whether GABAA α1β2(L285R)γ2 receptors also displayed enhanced spontaneous 
gating by applying picrotoxin (100 µM) to block spontaneous currents recorded in the absence of 
agonist (ISpont). Maximal GABA evoked currents (IGABA) were then recorded. We quantified the extent 
of spontaneous gating as the percentage of ISpont to IGABA (ISpont/IGABA). The β2(L285R) substitution 
conferred enhanced ISpont (Fig. 7). We investigated the effect of the α1(T47R) and α1(F64C) 
substitutions on these currents. However, GABA failed to activate α1(F64C)β2(L285R)γ2 receptors, 
while picrotoxin inhibited standing currents (n = 3; data not shown). Therefore our subsequent 
experiments were restricted to the α1(T47R) substitution. Figure 7A shows representative examples 
of ISpont (grey traces) and IGABA (black traces) mediated by α1β2γ2, α1β2(L285R)γ2 and 
α1(T47R)β2(L285R)γ2 receptors. The presence of the α1(T47R) substitution reduced the amplitude 
of ISpont relative to IGABA (Fig. 7A). The mean extent of spontaneous gating is plotted in Figure 7B. WT 
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α1β2γ2 receptors had negligible ISpont/IGABA (0.0008 ± 0.0002%; n = 6). By contrast, α1β2(L285R)γ2 
receptors had enhanced ISpont/IGABA (65 ± 12%; n = 4) and that of α1(T47R)β2(L285R)γ2 receptors was 
only 12 ± 5% (n = 4). A one-way ANOVA revealed a statistically significant difference in mean 
ISpont/IGABA (P < 0.0001). A post-hoc Tukey’s comparison revealed statistically significant differences 
between the mean ISpont/IGABA of α1β2γ2 and α1β2(L285R)γ2 receptors (P < 0.0001), and between 
α1β2(L285R)γ2 and α1(T47R)β2(L285R)γ2 receptors (P < 0.0001). Our data therefore demonstrate 
that the β2(L285R) substitution confers greatly enhanced spontaneous activity, but the α1(T47R) 
substitution attenuated this effect. This demonstrates that the α1(T47R) substitution reduces the 
gating of GABAA α1β2γ2 receptors independent of any agonist occupancy.  
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Discussion 
Data from this study and our previous study respectively demonstrate that two substitutions, T47R 
and D43C, at strategic locations in loop G reduce the apparent potency of GABA (Baptista-Hon et al., 
2016). Changes in apparent potency can be caused by reduced binding affinity and/or gating efficacy 
(Colquhoun, 1998). Both mechanisms contribute to the reduced apparent potency of GABA caused 
by the α1(F64C) loop D substitution (Szczot et al., 2014; Baptista-Hon et al., 2016). Loop D located in 
the β2 strand is critical for agonist binding in the GABAA receptor and, consistent with this, 
modification of Cys64 by MTSEA is hindered by GABA, but not by the allosteric agonists, propofol 
and pentobarbital (Holden & Czajkowski, 2002; Baptista-Hon et al., 2016). By contrast, we previously 
demonstrated that both GABA and propofol reduce the rate of MTSEA modification of Cys43 and 
Cys47 in α1(D43C)β2γ2 and α1(T47C)β2γ2 receptors, respectively (Baptista-Hon et al., 2016). This is 
consistent with movement associated with gating being the cause of reduced accessibility, rather 
than agonist binding. Movement of loop G during gating may be responsible for reduced accessibility 
to MTSEA. Furthermore, restriction of movement by non-conservative substitutions of amino acids 
at positions 43 and 47 may impair gating leading to the observed dextral shift in the GABA 
concentration-response relationship for α1(D43C)β2γ2 and α1(T47R)β2γ2 receptors relative to WT.  
We directly explored whether the α1(D43C) and α1(T47R) substitutions reduce GABA efficacy using 
propofol at a concentration below that required for activation, but sufficient for positive allosteric 
modulation of sub-maximal GABA-evoked currents mediated by WT receptors (Berger et al., 1997). 
Propofol potentiated maximal GABA-evoked currents mediated by both α1(D43C)β2γ2 and 
α1(T47R)β2γ2, but not WT receptors. This suggests that propofol restores the efficacy of GABA lost 
through the D43C and T47R substitutions in loop G. Using non-stationary variance analysis, we also 
demonstrated that the maximal Popen is reduced for α1(D43C)β2γ2 and α1(T47R)β2γ2 receptors, 
without a change in single channel conductance, indicating that loop G does indeed play a role in 
efficacy. Using the same approach, it was demonstrated that the loop D α1(F64C) substitution also 
reduces maximal Popen, albeit to a greater extent (Szczot et al., 2014). Our data showing that the 
magnitude of propofol potentiation of a maximally efficacious concentration of GABA was greater in 
α1(F64C)β2γ2 receptors, than in α1(D43C)β2γ2 and α1(T47R)β2γ2 receptors agrees well with the 
relative impairments of Popen associated with these substitutions. Furthermore, the efficacy of THIP 
was also reduced by loop G and loop D substitutions providing additional evidence that orthosteric 
agonist efficacy is indeed impaired. 
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Mounting structural evidence suggests that the antiparallel β1 and β2 strands, which contain loop G 
and loop D, respectively, move during gating. Comparisons of apo- and ligand-bound structures of 
the glycine receptor (Du et al., 2015), and the C. elegans GluCl (Althoff et al., 2014) reveal 
movements in the β1 and β2 strands. Molecular dynamic (MD) simulations of C. elegans GluCl 
deactivation show that the loop connecting β1 and β2 strands moves towards the TM2-3 loop 
(Calimet et al., 2013). This movement appears to precede conformational changes within the TM 
domains which lead to gating. Furthermore, mutations that prevent the electrostatic interaction 
between the β1-β2 loop and the TM2-3 loop in the GABAA α1 subunit reduce GABA efficacy (Kash et 
al., 2003). We have also previously demonstrated that substitution of the conserved α1 subunit 
TM2-3 Lys278 by methionine reduces the efficacy of GABA (Hales et al., 2006). These functional, 
structural and simulation data, together with our current findings, suggest that the movement of 
loop G residues is involved in a series of structural rearrangements required for normal channel 
gating. 
GABA-evoked currents mediated by α1(D43C)β2γ2 and α1(T47R)β2γ2 receptors exhibit a 
dramatically increased deactivation rate compared to WT receptors. There were also changes to 
apparent desensitisation kinetics and a tendency towards slowed activation rate. α1(F64C) and 
α1(F64T) substitutions in loop D caused more substantial changes in macroscopic current kinetics, 
with activation, apparent desensitisation and deactivation rates all significantly affected. This is 
consistent with the dual binding and gating role played by Phe64 in loop D (Boileau et al., 1999; 
Szczot et al., 2014). These changes in kinetics, particularly the observed increase in deactivation 
rates, are consistent with those we have previously observed for the α1(K278M) substitution, at the 
TM2-3 loop location, far removed from the agonist binding site, which also impairs agonist efficacy 
(Hales et al., 2006; Othman et al., 2012). In this case faster deactivation reflected a reduced mean 
open time. Reduced mean open time may also account for the increase in deactivation rates for 
α1(D43C)β2γ2 and α1(T47R)β2γ2 receptors as both substitutions caused reduced Popen compared to 
WT receptors.  
Ligand binding experiments indicate that GABA cannot dissociate from homomeric 1 receptors in 
the open channel conformation (Chang & Weiss, 1999). Similarly GABA becomes trapped in its 
binding sites on α1β3γ2 receptors and does not unbind until the channel closes (Bianchi & 
Macdonald, 2001). Therefore the deactivation time course is largely dictated by the mean open time 
of the receptor. Our data demonstrate that THIP-evoked currents deactivate faster than GABA-
evoked currents, consistent with single channel data demonstrating a shorter mean open time 
associated with activation by the partial agonist (Mortensen et al., 2004).  
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Our data indicate that the efficacy of THIP is severely impaired in the presence of the α1(T47R) 
substitution. It is worth noting that the macroscopic current kinetics of THIP-evoked currents in 
α1(T47R)β2γ2 receptors begin to resemble those with the loop D α1(F64C) and α1(F64T) 
substitutions. This may suggest that as agonist efficacy becomes progressively impaired, there may 
be incremental changes to activation, apparent desensitisation and deactivation rates. 
We have previously observed that reduced efficacy associated with the α1(K278M) substitution, was 
not restricted to GABA but also generalised to activation by propofol (Hales et al., 2006). Consistent 
with a similar scenario, propofol-evoked currents mediated by α1(T47R)β2γ2 receptors also 
deactivate faster than their WT counterparts, suggesting that the mean open times for propofol-
activated channels were also reduced by the α1(T47R) substitution. These data confirm that the 
α1(T47R) substitution impairs gating through a mechanism independent of orthosteric binding and 
suggest a common conformational rearrangement associated with activation by orthosteric and 
allosteric agonists.  
We also examined the effect of α1(T47R) substitution on spontaneous gating to further explore the 
generality of its ability to impair gating. Our previous work demonstrates that WT GABAA receptors 
exhibit a low level of spontaneous gating that can be blocked by the non-competitive inhibitor 
picrotoxin and the inverse agonist bicuculline (McCartney et al., 2007). The α1(K278M) substitution, 
which inhibits GABA and propofol efficacy also reduces spontaneous gating (Othman et al., 2012).  
In order to examine the effects of the loop G and loop D substitutions on gating that is independent 
of any agonist, we used the L285R substitution in the β2 subunit to enhance spontaneous gating. A 
previous study of β1(L285R) demonstrated that the substitution caused a large increase in GABA-
independent gating (Anstee et al., 2013). Consistent with this, α1β2(L285R)γ2 receptors also 
exhibited marked spontaneous currents that were inhibited by picrotoxin. Spontaneous gating was 
reduced in α1(T47R)β2(L285R)γ2 compared to α1β2(L285R)γ2 receptors confirming that, like 
α1(K278M), α1(T47R) impairs gating independently of agonist activation. 
In summary this study suggests that movement of loop G in the β1 strand of the GABAA receptor α1 
subunit is involved in a conformational rearrangement associated with channel activation. The non-
conservative replacements of Asp43 and Thr47 reduce efficacy presumably by impeding movement 
of the entire β1-β2 antiparallel loop structure. The importance of this region of pLGICs in activation 
by orthosteric agonists might have been predicted by structural data and MD simulations (Calimet et 
al., 2013; Althoff et al., 2014; Du et al., 2015).  
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Kinetic models of glycine and nicotinic acetylcholine receptor gating incorporate pre-open shut 
states, termed flip and prime, respectively (Burzomato et al., 2004; Mukhtasimova et al., 2009). The 
rates of transition into these states correlate with agonist efficacy (Lape et al., 2008). It is therefore 
not a surprise that the α1(F64C) substitution in loop D, which reduces the efficacy of GABA, also 
reduces the transition rate constants into the flip state (Szczot et al., 2014). It is possible that the 
D43C and T47R substitutions also hinder these pre-open transitions. Perhaps more surprisingly, 
however, the T47R substitution also impairs gating that is independent of orthosteric (or indeed 
allosteric) agonist activation.  
A requirement for the movement of loop G residues during agonist independent gating may provide 
a mechanism for the negative efficacy that is characteristic of inverse agonism. It is possible that 
bicuculline inhibits GABAA receptor gating, caused by either allosteric or spontaneous activation, by 
immobilising the antiparallel β1-β2 strand structure (McCartney et al., 2007). Additional structural 
studies will be required to test this hypothesis. 
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Figure legends 
Figure 1. Loop G and loop D of C. elegans GluCl and GABAA receptor α subunits. A, Amino acid 
sequence alignment of the mouse GABAA α1 to α6 subunits and GluCl α subunit. The β1 and β2 
strands are highlighted in green and red, respectively. Residues in loop G and D of the GABAA α1 
subunit are underlined. Also underlined are the homologous residues on the GABAA α2 to α6 and 
GluCl which are relevant to this study. B, The C. elegans GluCl (Hibbs & Gouaux, 2011) model, 
showing the interface between two subunits (blue – primary interface, yellow – complimentary 
interface) with the β1 and β2 strands highlighted (green and red, respectively). Bound glutamate is 
shown in grey. Inset shows the highlighted area in more detail. Asn33 and Arg37 are shown on the 
β1 strand as stick rendering in green. Thr54 is shown on the β2 strand as stick rendering in red. C, 
Representative examples of whole-cell currents evoked by a maximal and an approximate EC50 
concentration of GABA (indicated) mediated by α1β2γ2 or α1(T47R)β2γ2 GABAA receptors. The bar 
indicates GABA application (2 s). D, Concentration-response relationships for α1β2γ2 (circles) or 
α1(T47R)β2γ2 (triangles) receptors. Current amplitudes were expressed as a percentage of the 
maximum current amplitude recorded from each cell. The sigmoidal curve represents the logistic 
function fitted to the data points. 
 
Figure 2. The identity of Loop G and loop D residues influences agonist efficacy. A, Representative 
examples of whole-cell currents mediated by α1β2γ2, α1(D43C)β2γ2 α1(T47R)β2γ2 or α1(F64C)β2γ2 
receptors evoked by a maximal concentration of GABA alone (black traces) or in the presence of 1 
µM propofol (grey traces). The concentration of GABA used was 1 mM for α1β2γ2, 300 mM for 
α1(D43C)β2γ2 and 30 mM for α1(T47R)β2γ2 and 300 mM for α1(F64C)β2γ2 receptors. Propofol 
potentiated GABA-evoked currents mediated by α1(D43C)β2γ2, α1(T47R)β2γ2 and α1(F64C)β2γ2 
receptors. B, Bar graph shows mean percentage potentiation by propofol. Propofol significantly 
potentiated GABA-evoked currents mediated by α1(D43C)β2γ2, α1(T47R)β2γ2 and α1(F64C)β2γ2 
receptors (* P < 0.05, P < 0.001 and P < 0.0001, respectively; one-way ANOVA post-hoc Tukey’s 
comparison). There was also a statistically significant difference between α1(F64C)β2γ2 receptors 
and α1(D43C)β2γ2 or α1(T47R)β2γ2 receptors (# P < 0.05 and P < 0.001, respectively; one-way 
ANOVA post-hoc Tukey’s comparison).  
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Figure 3. Maximal Popen is reduced in α1(D43C)β2γ2 and α1(T47R)β2γ2 receptors. A, Representative 
examples of variance and mean current calculated from 10 consecutive GABA applications to α1β2γ2 
or α1(T47R)β2γ2 receptors. The application of GABA is indicated by the liquid junction current above 
each trace. Only the variance and mean current values following the peak of the current (black) were 
used in the analysis. B, Mean current versus variance plot for α1β2γ2 or α1(T47R)β2γ2 receptors. 
The dotted line represents the parabolic function fitted to the data points. C, Bar graph of mean 
single channel conductances. The single channel conductance for α1β2γ2, α1(D43C)β2γ2 and 
α1(T47R)β2γ2 receptors were 26 ± 3.2 pS (n = 8), 27 ± 2.9 pS (n = 7) and 26 ± 2.3 pS (n = 5) 
respectively. There was no significant difference between the means (P = 0.96; one-way ANOVA). D, 
Bar graph of mean maximal Popen for α1β2γ2, α1(D43C)β2γ2 and α1(T47R)β2γ2 receptors. There was 
a statistically significant difference in Popen between α1β2γ2 and α1(D43C)β2γ2 receptors and 
between WT α1β2γ2 and α1(T47R)β2γ2 receptors (* P <0.05; one-way ANOVA; post-hoc Tukey’s 
comparison). 
Figure 4. The kinetics of GABA-evoked currents mediated by α1β2γ2, α1(D43C)β2γ2, α1(T47R)β2γ2, 
α1(F64C)β2γ2 and α1(F64T)β2γ2 receptors. A, Representative examples of GABA-evoked currents 
mediated by α1β2γ2, α1(D43C)β2γ2, α1(T47R)β2γ2 and α1(F64C)β2γ2 receptors recorded from 
outside-out patches. The associated square pulses indicate the junction currents corresponding to 
agonist application. B, (inset) Representative examples of amplitude-normalised activation phases of 
GABA-evoked currents mediated by α1β2γ2 (black), α1(T47R)β2γ2 (grey) or α1(F64C)β2γ2 (grey) 
receptors. Bar graph shows mean 10-90% rise time of current activation. Both α1(F64C) and 
α1(F64T) substitutions significantly slowed the GABA-activation rate when compared with α1β2γ2 
receptors (* P < 0.0001; one-way ANOVA post-hoc Tukey’s comparison) and with α1(D43C)β2γ2 or 
α1(T47R)β2γ2 receptors (# P < 0.0001; one-way ANOVA post-hoc Tukey’s comparison). C, Bar graph 
shows the mean percentage current remaining. GABA-evoked currents mediated by α1(D43C)β2γ2, 
α1(F64C)β2γ2 and α1(F64T)β2γ2 receptors desensitise significantly less, when compared with 
α1β2γ2 receptors (P < 0.05; P < 0.001 and P < 0.001, respectively; one-way ANOVA post-hoc Tukey’s 
comparison). D, Mean desensitisation τw of α1β2γ2, α1(D43C)β2γ2 and α1(T47R)β2γ2 receptors. 
There was no statistically significant difference in mean τw (P = 0.08; one-way ANOVA). The individual 
components of the multi-exponential fit is summarised in Table 1. E, (inset) Representative examples 
of amplitude-normalised current deactivation following agonist removal. The superimposed traces 
are time-shifted for clarity. The step above each trace indicates the liquid junction current 
corresponding to agonist removal. The bar graph shows mean deactivation τw. GABA-evoked 
currents mediated by α1(D43C)β2γ2, α1(T47R)β2γ2, α1(F64C)β2γ2 and α1(F64T)β2γ2 receptors 
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deactivated significantly faster when compared to those mediated by α1β2γ2 receptors (* P < 
0.0001; one-way ANOVA post-hoc Tukey’s comparison). The individual components of the multi-
exponential fits are summarised in Table 2. 
Figure 5. The kinetics of GABA- and THIP-evoked currents mediated by α1β2γ2 or α1(T47R)β2γ2 
receptors. A, Representative examples of maximal GABA- (black) and THIP-evoked (grey) currents 
recorded from excised outside-out patches containing α1β2γ2 or α1(T47R)β2γ2 receptors. The 
upward (black) and downward (grey) steps above each correspond to the liquid junction current for 
GABA and THIP application, respectively. B, The mean maximum THIP-evoked current amplitude (as 
percentage of maximal GABA current amplitude) was significantly less than the maximum GABA-
evoked current amplitude at α1β2γ2 receptors (# P = 0.002; paired t-test). The efficacy of THIP was 
significantly reduced at α1(T47R)β2γ2 receptors (* P = 0.0001; t-test). C, Representative examples of 
the activation phases of GABA- (black) and THIP-evoked (grey) currents recorded from excised 
outside-out patches containing α1β2γ2 receptors. The associated graph illustrates the mean 10-90% 
rise times. THIP-evoked currents activated significantly slower than GABA-evoked currents (* P = 
0.0001; t-test). D, Bar graph shows mean desensitisation τw. THIP-evoked currents desensitised 
significantly more slowly than GABA-evoked currents (* P = 0.0011; t-test). E, Representative 
examples show amplitude-normalised deactivation phases of GABA- (black) and THIP-evoked (grey) 
currents. Bar graph shows mean deactivation τw. THIP-evoked currents deactivated significantly 
faster than GABA-evoked currents (* P = 0.0001; t-test). F, Representative activation phases of THIP-
evoked currents from outside-out patches containing α1β2γ2 (black) and α1(T47R)β2γ2 (grey) 
receptors. Bar graph shows mean 10-90% rise times. The α1(T47R) substitution significantly slowed 
the activation rates of THIP-evoked currents, as compared to WT receptors (* P = 0.002; t-test). G, 
Bar graph shows mean percentage current remaining. THIP-evoked currents show less 
desensitisation as compared to α1β2γ2 receptors (* P = 0.0001; t-test). H, Representative examples 
of amplitude-normalised deactivation phases of THIP-evoked currents mediated by α1β2γ2 (black) 
and α1(T47R)β2γ2 (grey) receptors. Bar graph shows mean deactivation τw. The α1(T47R) 
substitution significantly increased deactivation rate (* P = 0.0001; t-test). 
Figure 6. The kinetics of propofol-evoked currents mediated by α1β2γ2, α1(T47R)β2γ2 and 
α1(F64C)β2γ2 receptors. A, Representative examples of propofol-evoked currents mediated by 
α1β2γ2, α1(T47R)β2γ2 and α1(F64C)β2γ2 receptors recorded from excised outside-out patches. The 
square pulse above each trace indicates the time-course of solution exchange. B, Representative 
examples of amplitude-normalised activation phases of propofol-evoked currents mediated by 
α1β2γ2 (black), α1(T47R)β2γ2 (grey) and α1(F64C)β2γ2 (grey) receptors. The bar graph shows the 
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mean 10-90% rise time of current activation. There were no statistically significant differences in the 
activation rates of propofol-evoked currents. C, Representative examples of amplitude-normalised 
decaying phases of the currents depicted in A, following propofol removal. The superimposed traces 
are time-shifted for clarity. The step above each trace indicates the liquid junction current 
corresponding to agonist removal. The bar graph shows mean deactivation τw. Propofol-evoked 
currents mediated by α1(T47R)β2γ2 and α1(F64C)β2γ2 receptors deactivated significantly faster 
when compared to those mediated by α1β2γ2 receptors (* P < 0.0001 for both; one-way ANOVA 
post-hoc Tukey’s comparison). Mean kinetic parameters are summarised in Table 1. 
Figure 7. Spontaneous gating mediated by α1β2γ2, α1β2(L285R)γ2 and α1(T47R)β2(L285R)γ2 
receptors. A, Representative examples of GABA-evoked currents (black traces) and inhibition of 
spontaneous currents by picrotoxin (grey traces) mediated by α1β2γ2, α1β2(L285R)γ2 and 
α1(T47R)β2(L285R)γ2 receptors. B, Bar graph shows mean percentage spontaneous current 
(expressed as ISpont/IGABA). One-way ANOVA revealed a statistically significant difference in mean 
spontaneous current (P < 0.0001). Mean spontaneous current amplitudes differed between α1β2γ2 
and α1β2(L285R)γ2 receptors (* P < 0.0001) and between α1β2(L285R)γ2 and α1(T47R)β2(L285R)γ2 
receptors (# P < 0.0001; post-hoc Tukey’s comparison).  
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Table 1. Summary of desensitisation components. 
 Agonist τf %f τm %m τs %s τw 
α1β2γ2 
GABA 
3.2 ± 
0.34 
27 ± 3.0 36 ± 6.3 30 ± 6.0 410 ± 49 43 ± 4.5 190 ± 25 
THIP 4.6 
7.5 ± 5.8 
#
 
33 ± 5.9 31 ± 5.0 350 ± 34 
61 ± 6.5 
#
 
240 ± 35 
α1(D43C)β2γ2 GABA 
6.7 ± 1.9 
* 
21 ± 6.1 42 ± 7.0 11 ± 4.3 
460 ± 
110 
68 ± 7.0 
* 
320 ± 87 
α1(T47R)β2γ2 GABA 
4.6 ± 
0.94 
13 ± 3.7 
* 
50 ± 7.7 18 ± 3.7 
790 ± 
220 
69 ± 4.6 
* 
570 ± 
170 
#
 P < 0.05 (unpaired t-test) compared with the equivalent WT GABA-evoked current value.  
* P < 0.05 (one-way ANOVA post-hoc Tukey’s comparison) compared with GABA-evoked currents mediated by α1β2γ2 
receptors.  
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Table 2. Summary of deactivation components. 
 Agonist τf %f τm %m τs %s τw 
α1β2γ2 
GABA 11 ± 2.0 
8.1 ± 
3.7 
47 ± 5.6 61 ± 5.2 270 ± 54 30 ± 5.0 100 ± 17 
THIP 3.2 ± 0.89 
# 
40 ± 
8.4 
#
 
12 ± 1.7 
#
 
61 ± 7.1 68 ± 13 
#
 6.1 ± 1.5 
#
 12 ± 1.4 
#
 
α1(D43C)β2γ2 GABA 7.9 ± 1.8 
64 ± 
3.1 * 
45 ± 12 
28 ± 2.6 
* 
280 ± 
110 
7.5 ± 2.6 
* 
34 ± 8.7 * 
α1(T47R)β2γ2 
GABA 
0.91 ± 
0.094 * 
73 ± 
5.4 * 
8.4 ± 2.2 
25 ± 5.3 
* 
140 ± 27 
2.3 ± 0.32 
* 
4.4 ± 0.47 
* 
THIP 
0.93 ± 
0.076 
93 ± 
1.6 
#
 
20 ± 4.5 
#
 
7.0 ± 1.6 
#
 
NA NA 
2.2 ± 0.46 
#
 
α1(F64C)β2γ2 GABA 1.9 ± 0.62 *  
91 ± 
5.4 * 
42 ± 15 
8.5 ± 5.4 
* 
NA NA 
3.5 ± 1.3 
* 
α1(F64T)β2γ2 GABA 
0.83 ± 
0.071 * 
93 ± 
1.5 * 
72 ± 24 
6.6 ± 1.5 
* 
NA NA 
6.2 ± 2.5 
* 
#
 P < 0.05 (unpaired t-test) compared with the equivalent GABA-evoked current value.  
* P < 0.05 (one-way ANOVA post-hoc Tukey’s comparison) compared with GABA-evoked currents mediated by α1β2γ2 
receptors.  
NA – not applicable due to a loss of this component. 
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